Tuesday, October 17, 2017 1:14:19 PM
1 hour ago - [color=red]ACQUIREMEDIA
As of 17 Oct 2017 at 12:51 PM EDT[img][/img]
Families Of Americans Killed And Injured By Iranian-Backed Iraqi Militia Sue Medical Companies For Allegedly Engaging In A Continuing Bribery Scheme That Supports Terrorism
WASHINGTON, Oct. 17, 2017 /PRNewswire/ -- A group of American veterans and civilians, and their families, filed a lawsuit against five major pharmaceutical and medical-supply corporations in federal court today, accusing the companies of knowingly or recklessly supporting an Iraqi terrorist group that attacked, killed, and wounded thousands of Americans in Iraq. Financing of this group allegedly has come via a longstanding and continuing bribery scheme that many of the defendants have pursued for years and was designed to keep their profits high.
The defendants being sued are the parent companies and/or subsidiaries of AstraZeneca plc (AZN), General Electric Company (GE), Johnson & Johnson (JNJ), Pfizer Inc. (PFE), and Roche Holding AG (RHHBY).
The defendants are being sued under the Anti-Terrorism Act by more than 100 Americans who were attacked or who had a family member attacked by the terrorist group Jaysh al-Mahdi (also known as JAM or the Mahdi Army).
Jaysh al-Mahdi is led by Muqtada al-Sadr, a notorious Iraqi cleric known for his fiery anti-American sermons and brutal attacks on Americans serving in Iraq after the fall of Saddam. As alleged in the complaint, Jaysh al-Mahdi has carried out its campaign of terror in Iraq using money and material provided directly by the defendants.
The suit follows an extensive investigation by the Washington, D.C.-based law firms of Sparacino & Andreson PLLC and Kellogg, Hansen, Todd, Figel & Frederick, PLLC.
"While Americans worked to rebuild Iraq, many were attacked by a terrorist group that we allege has been funded in part by the defendants' corrupt sales practices," said Josh Branson, a partner at Kellogg Hansen. "This lawsuit alleges that the defendants have aided and abetted terrorism in Iraq by paying bribes to the terrorists who ran the Iraqi Ministry of Health. We allege that those corrupt payments, including cash and free goods, provided an important source of financing for the terrorists."
Jaysh al-Mahdi is effectively the Iraqi franchise of Hezbollah, a Lebanese terrorist organization, and serves as Iran's terrorist proxy in Iraq. The complaint alleges that Jaysh al-Mahdi's terrorist attacks against Americans in Iraq have been planned, authorized, and sometimes conducted by Hezbollah.
"As alleged, many of the defendants have a documented history of paying bribes that supported terrorism under Saddam," said Ryan Sparacino, a partner at Sparacino & Andreson. "We believe that the evidence will show that when Jaysh al-Mahdi seized the Iraqi Health Ministry, the defendants continued paying the same bribes that many of them provided under Saddam – except in far greater amounts. The complaint alleges that these corruption schemes are extensive and ongoing. The lives of the families of those killed and injured have been forever changed, and the results have been devastating."
Kellogg Hansen and Sparacino & Andreson conducted an extensive investigation before filing the complaint. The firms spent thousands of hours working on the matter and analyzing hundreds of transactions between the defendants and the Iraqi Health Ministry. For many of the survivors of these attacks and the families of those killed, much of what the investigation uncovered came as a shock.
"My hope is that we can get justice for my brother's death and for so many others who didn't have to die in Iraq," said Ami Neiberger-Miller, the surviving sister of U.S. Army Specialist Christopher Neiberger, who was killed in action in Baghdad, Iraq on August 6, 2007, three days after his 22nd birthday.
The complaint is available at http://www.terrorismcase.com.
View original content:http://www.prnewswire.com/news-releases/families-of-americans-killed-and-injured-by-iranian-backed-iraqi-militia-sue-medical-companies-for-allegedly-engaging-in-a-continuing-bribery-scheme-that-supports-terrorism-300538096.html
SOURCE Sparacino & Andreson PLLC
Recent AUPH News
- New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference • Business Wire • 04/16/2024 02:48:00 PM
- Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024 • Business Wire • 04/15/2024 10:00:00 AM
- Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference • Business Wire • 04/09/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:44:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:43:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:42:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:41:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:10:10 PM
- Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program • Business Wire • 02/29/2024 01:30:00 PM
- Aurinia to Participate in Upcoming Investor Healthcare Conferences • Business Wire • 02/27/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:35:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:33:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:31:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:29:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 09:27:55 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 02/22/2024 09:19:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/15/2024 11:16:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 11:06:50 AM
- Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value • Business Wire • 02/15/2024 11:00:00 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:27:55 PM
- Aurinia Pharmaceuticals to Release 2023 Fourth Quarter and Full Year Financial and Operational Results on February 15, 2024 • Business Wire • 02/05/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 11:02:28 AM
- Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue Results • Business Wire • 01/05/2024 11:00:00 AM
- Aurinia Submits IND Application to US Food & Drug Administration for AUR 200 • Business Wire • 12/20/2023 11:00:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM